Table 1.
Clinical data
|
Variables |
Patients |
Controls |
p-value |
|---|---|---|---|
| (n = 98) | (n = 102) | ||
| Current age, years |
29 (19–44) |
24 (18–35) |
<0.001 |
| Duration of PVD, years |
8 (0,5-18) |
- |
- |
| Primary PVD |
35 (36%) |
- |
- |
| Secondary PVD |
63 (64%) |
- |
- |
| Current use of hormonal contraceptives |
33 (34%) |
53 (52%) |
0.005 |
| Combined hormonal contraceptives |
26 (27%) |
42 (40%) |
ns |
| Progestogen only contraceptives |
7 (7%) |
11 (11%) |
ns |
| Menstrual cycle day |
7.9 (4–13) |
8.0 (3–13) |
ns |
|
Concomitant pain |
|
|
|
| Dysmenorrhea |
67 (71%) |
55 (54%) |
0.02 |
| Headache |
59 (60%) |
30 (29%) |
<0.001 |
| GI pain and dysfunction |
53 (54%) |
22 (22%) |
<0.001 |
| Back pain |
48 (49%) |
20 (20%) |
<0.001 |
| Muscle pain |
31 (32%) |
2 (2%) |
<0.001 |
| Other pain | 26 (27%) | 1 (1%) | <0.001 |
PVD = provoked vestibulodynia, GI = gastro-intestinal.